Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Boryung Co. Ltd. (003850:KRX), powered by AI.
Boryung Co. Ltd. is currently trading at ₩9,250. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Boryung Co. Ltd. on Alpha Lenz.
Boryung Co. Ltd.'s P/E ratio is 12.3.
“Boryung Co. Ltd. trades at a P/E of 12.3 (undervalued) with modest ROE of 7.9%. 3Y revenue CAGR of 10.2% highlights clear growth momentum.”
Ask for details →Boryung Co. Ltd. is a renowned pharmaceutical company based in South Korea, specializing in the development, manufacturing, and distribution of medical products. Known for its commitment to healthcare innovation, Boryung Co. Ltd. primarily focuses on producing essential pharmaceuticals, including antibiotics, cardiovascular medications, and oncology drugs. This firm plays a crucial role in enhancing public health by providing high-quality, affordable medical solutions. Operating within the dynamic and highly regulated pharmaceutical industry, Boryung Co. Ltd. collaborates with various healthcare providers to ensure its products meet global safety and efficacy standards. With a presence in both domestic and international markets, the company leverages cutting-edge research and development capabilities to address emerging health challenges and cater to a diverse patient population. Boryung Co. Ltd.'s impact extends beyond drug manufacturing, as it also engages in strategic partnerships and alliances to enhance its offerings and reach. Its market presence exemplifies the vital role pharmaceuticals play in both economic growth and social welfare, reinforcing its status as a pivotal player in advancing healthcare solutions worldwide.
“Boryung Co. Ltd. trades at a P/E of 12.3 (undervalued) with modest ROE of 7.9%. 3Y revenue CAGR of 10.2% highlights clear growth momentum.”
Ask for details →Boryung Co. Ltd. (ticker: 003850) is a company listed on KRX in the Healthcare sector (Drug Manufacturers - Specialty & Generic). It has approximately 1,533 employees. Market cap is $793.5B.
The current price is ₩9,250 with a P/E ratio of 12.34x and P/B of 0.94x.
ROE is 7.89% and operating margin is 6.40%. Annual revenue is $1.0T.